Assessment of Ototoxicity in Patients With Heart Failure Receiving High-Dose IV Loop Diuretics

医学 队列 耳毒性 利尿剂 危险系数 内科学 测听 利尿剂 队列研究 速尿 加药 听力损失 儿科 心力衰竭 回顾性队列研究 门诊部 前瞻性队列研究 外科 纯音测听 回廊的 感音神经性聋
作者
Zachary L. Cox,Veena S. Rao,Juan Betuel Ivey-Miranda,Sarah Myers,Kennedy Manning,Brant Imhoff,Cathy A. Jenkins,Matthew Stephen Shotwell,Karen F. Miller,Alan B. Storrow,Pamela Watson,Aldo Rivera-Sanchez,F. Perry Wilson,Yu Yamamoto,Hasan Khalid Siddiqi,Kelly H. Schlendorf,Lynne Warner Stevenson,JoAnn M. Lindenfeld,Leonard P. Rybak,Sean P. Collins
出处
期刊:JAMA Cardiology [American Medical Association]
标识
DOI:10.1001/jamacardio.2026.4913
摘要

Importance: Concern for ototoxicity hinders loop diuretic (LD) dosing in heart failure (HF); given the mechanism by which LDs affect the ear, high-dose LDs should produce transient, not permanent, hearing changes. Objective: To measure the association of LD dose with permanent and temporary ototoxicity. Design, Setting, and Participants: Cohort 1 received a randomized sequence of LD doses (bumetanide, 1.25-10 mg) across study visits with serial audiometry assessments. Cohort 2 received serial LD up to furosemide 500-mg doses during a HF hospitalization with audiometry at baseline and prior to discharge. Cohort 3 retrospectively characterized clinically diagnosed ototoxicity in HF hospitalizations was defined using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) codes. Cohorts 1 and 2 were single center, while cohort 3 was multicenter. Cohort 1 studied outpatient participants with stable HF, while cohort 2 (n = 40) and cohort 3 studied hospitalized patients with acute HF. Exposure: Intravenous LD. Main Outcomes and Measures: The primary outcomes were clinically diagnosed ototoxicity and hearing changes via audiometry. Results: Cohort 1 contained 50 participants, cohort 2 contained 40 participants, and cohort 3 contained 22 656 participants. In cohort 1, mean (SD) participant age was 63.2 (10.4) years, and 21 of 50 participants (42%) were women. In cohorts 1 and 2, clinically diagnosed ototoxicity was not observed. In cohort 1, at peak diuretic concentration, worsening hearing shifts were infrequent (24 ears of 400 doses [6%]) but were more common with higher doses (odds ratio [OR], 1.99; 95% CI, 1.21-3.28 per doubling dose; P = .007). Within hours, hearing shifts largely resolved and were absent in 98% of measurements (393 ears of 400 doses). No significant association between LD dose and hearing shifts was present at any time aside from peak LD concentration. In cohort 2, hearing shifts were not different across groups divided by the median daily LD dose and were not associated with LD dose (OR, 1.19; 95% CI, 0.71-1.98 per doubling dose; P = .52). In cohort 3, 608 HF hospitalizations (2.7%) had clinically diagnosed ototoxicity. In multivariable analyses, peak dose of 160 mg furosemide equivalents or greater (OR, 0.83; 95% CI, 0.52-1.31; P = .43) and 400 mg furosemide equivalents or greater (OR, 1.28; 95% CI, 0.71-2.31; P = .41) were not associated with greater clinically diagnosed ototoxicity risk relative to less than 160 mg. Conclusions and Relevance: In this analysis of 2 small HF cohorts, short-term exposure to high-dose LD was not associated with permanent ototoxicity, although concomitant ototoxin use was excluded. Future studies are needed to understand the risk of ototoxicity with repeated LD exposure and in broader HF populations. Trial Registration: ClinicalTrials.gov Identifiers: NCT04481919 and NCT05323487.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Alex完成签到,获得积分0
1秒前
雪雨夜心完成签到,获得积分10
1秒前
1秒前
yawyl完成签到,获得积分10
1秒前
飘逸的思萱完成签到 ,获得积分10
2秒前
Mr.egg发布了新的文献求助10
2秒前
djfndnn完成签到 ,获得积分10
2秒前
2秒前
Shy完成签到,获得积分10
2秒前
TTM完成签到 ,获得积分10
3秒前
zwhy579完成签到 ,获得积分10
3秒前
小马甲的应助被刘留流六采纳,获得10
3秒前
stuffmatter完成签到,获得积分0
3秒前
CWJ完成签到,获得积分10
4秒前
wxh完成签到 ,获得积分10
4秒前
王兔岁完成签到,获得积分10
5秒前
5秒前
5秒前
Tian发布了新的文献求助10
6秒前
liupeng0403117完成签到,获得积分10
6秒前
李半斤完成签到,获得积分10
6秒前
7秒前
时光可喜完成签到,获得积分10
7秒前
自觉的宇完成签到 ,获得积分10
7秒前
yzee完成签到,获得积分10
7秒前
无语的南风完成签到,获得积分10
7秒前
空格TNT完成签到 ,获得积分10
7秒前
CY完成签到,获得积分10
7秒前
赘婿的应助被星星采纳,获得10
8秒前
科研通AI6.2的应助被CC采纳,获得10
8秒前
他说发布了新的文献求助10
8秒前
9秒前
流星逐月完成签到,获得积分10
9秒前
9秒前
lucky完成签到,获得积分10
10秒前
Therealyori完成签到 ,获得积分10
10秒前
TTM关注了科研通微信公众号
10秒前
Zen完成签到,获得积分10
10秒前
HOH完成签到,获得积分10
10秒前
桐桐的应助被拼搏的似狮采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180407
求助须知:如何正确求助?哪些是违规求助? 9570403
关于积分的说明 21811831
捐赠科研通 7776452
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557499
邀请新用户注册赠送积分活动 2479105